Precipio Inc. Common Stock (PRPO)
Stock · NASDAQ · Industrials
$21.64as of 10/16/2026
Price chart
Active signals
PRPO Signal Track Record
How signals performed across all stocks →What PRPO's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Bollinger Band Breakout | 24 | -4.7% | 38% | August 19, 2026 |
| Volume Spike | 21 | +2.3% | 57% | September 17, 2026 |
| Bollinger Band Breakdown | 19 | +3.6% | 53% | September 23, 2026 |
| 200-Day Moving Average TouchActive now | 11 | 0.0% | 45% | August 18, 2026 |
| Any 20-session window (baseline) | -0.8% | 47% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About PRPO
Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers HemeScreen, a suite of robust genetic diagnostic panels; and IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages. It offers biomarker testing and clini…
- Sector
- Industrials
- Industry
- Biotechnology: Laboratory Analytical Instruments
- Employees
- 61
- Website
- www.precipiodx.com/
Fundamentals
- 1-day range
- $21.5$22.5
- Market cap
- $41.93M
- P/E (trailing)
- —
- P/E (forward)
- 55.54
- EPS (trailing)
- $-0.68
- Dividend yield
- —
- Beta
- 1.44
- Avg. volume
- 118.6K
- Dividend pay date
- April 29, 2019
How Precipio Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 30, 2026 · via SEC EDGAR / Finnhub
Precipio Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- PRPOPrecipio Inc. Common Stock$21.38▼ 5.17%Market cap $41.93MP/E —$16.4$33.63
- HBIOHarvard Bioscience Inc. Common Stock$8.09▼ 2.65%Market cap $27.92MP/E —$3.75$9.4
- ASTCAstrotech Corporation (DE) Common Stock$4.93▼ 5.19%Market cap $18.10MP/E —$1.92$68.85
- CIRCCircle8 Group Inc. Common Stock$0.302▼ 5.33%Market cap $70.73MP/E —$0.3132$0.98
- BNGOBionano Genomics Inc. Common Stock$1.25▼ 8.76%Market cap $12.62MP/E —$1$2.23
- RPIDRapid Micro Biosystems Inc. Class A Common Stock$0.764▼ 9.59%Market cap $96.03MP/E —$0.8087$4.94
- NAUTNautilus Biotechnology Inc. Common Stock$2.06▼ 4.63%Market cap $112.76MP/E —$0.8399$4.31
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| PRPO Precipio Inc. Common Stock | $41.93M | — | $21.38 | ▼ 5.17% | $16.4$33.63 |
| HBIO Harvard Bioscience Inc. Common Stock | $27.92M | — | $8.09 | ▼ 2.65% | $3.75$9.4 |
| ASTC Astrotech Corporation (DE) Common Stock | $18.10M | — | $4.93 | ▼ 5.19% | $1.92$68.85 |
| CIRC Circle8 Group Inc. Common Stock | $70.73M | — | $0.302 | ▼ 5.33% | $0.3132$0.98 |
| BNGO Bionano Genomics Inc. Common Stock | $12.62M | — | $1.25 | ▼ 8.76% | $1$2.23 |
| RPID Rapid Micro Biosystems Inc. Class A Common Stock | $96.03M | — | $0.764 | ▼ 9.59% | $0.8087$4.94 |
| NAUT Nautilus Biotechnology Inc. Common Stock | $112.76M | — | $2.06 | ▼ 4.63% | $0.8399$4.31 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- PRPO vs. FLGT: Which Cancer Diagnostics Stock Has More Upside Now?Yahoo · 9/22/2026
- Precipio Q2 2026 Earnings Call: Complete TranscriptBenzinga · 9/18/2026
- The Zacks Analyst Blog Highlights Goldman Sachs, RTX, Abbott, NLI and PrecipioYahoo · 9/11/2026
Insider Activity
Insider Actions →- Christina Rizopoulos Valauri · July 15, 2026 · Grant108 @ $25.24
- Jeffrey Cossman · July 15, 2026 · Grant416 @ $25.24
- David Seth Cohen · July 15, 2026 · Grant520 @ $25.24
- Richard A. Sandberg · May 21, 2026 · Sale900 @ $25.02
- Richard A. Sandberg · May 20, 2026 · Sale2.0K @ $24.89
- Richard A. Sandberg · May 20, 2026 · Sale500 @ $25
- Richard A. Sandberg · May 19, 2026 · Sale600 @ $24.42
- Christina Rizopoulos Valauri · April 15, 2026 · Grant93 @ $29.49
- Jeffrey Cossman · April 15, 2026 · Grant365 @ $29.49
- David Seth Cohen · April 15, 2026 · Grant445 @ $29.49
Institutional Ownership
March 31, 2026
- Total shares held
- 142.3K
- Total value held
- $3.61M
- Institutional holders
- 14
- Unknown29.0K
- Unknown25.5K
- Unknown24.6K
- Unknown19.3K
- Unknown18.8K
- Unknown15.1K
- Unknown9.5K
- Unknown227
- Unknown138
- Unknown50
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Precipio Management Signals Growth, Institutions Take Interest
Precipio’s leadership outlined ambitious plans for future growth, drawing attention from institutional investors. The company’s strategy includes expanding its product line and entering new markets. Institutional involvement suggests confidence in the company’s direction. The move may influence investor sentiment and the stock’s short‑term activity.
Precipio Management Signals Growth, Institutions Take Interest. Precipio’s leadership outlined ambitious plans for future growth, drawing attention from institutional investors. The company’s strategy includes expanding its product line and entering new markets. Institutional involvement suggests confidence in the company’s direction. The move may influence investor sentiment and the stock’s short‑term activity.